Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Moderna’s Collaboration with Generation Bio
Goodwin advised Moderna, Inc. on the deal. Moderna, Inc. (Nasdaq:MRNA) announced its strategic collaboration with Generation Bio Co. (Nasdaq:GBIO) to combine Moderna’s biological and technical expertise with...
Symphony Technology Group’s $1.5 Billion Acquisition of Momentive
Goodwin Procter advised Qatalyst Partners on the deal. Qatalyst Partners acted as financial advisor to Momentive (Nasdaq: MNTV) in a definitive agreement to be acquired by a...
PTC’s $1.46 Billion Acquisition of ServiceMax
Goodwin Procter advised PTC on the deal, Ropes & Gray represented ServiceMax, Latham & Watkins represented Centerview Partners. PTC (NASDAQ: PTC) signed its definitive agreement to acquire...
Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.
Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
Citrix Systems’ $16.5 Billion Acquisition of Vista Equity Partners and Evergreen Coast Capital’s Affiliates
Goodwin Procter advised Citrix Systems on the deal. Citrix Systems announced its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital Corporation, an affiliate of...
Walgreens Boots Alliance’s US$1.37 Billion Acquisition of Shields Health Solutions
Sidley represented Walgreens Boots Alliance, Ropes & Gray advised Welsh, Carson, Anderson & Stowe, while Goodwin Procter and K&L Gates advised Shields on the deal. Walgreens...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Amazon.com’s $1.7 Billion Acquisition of iRobot Corporation
Goodwin Procter advised iRobot Corporation on the deal, while Paul, Weiss advised Amazon. iRobot Corporation (NASDAQ: IRBT) announced its definitive agreement to be acquired by Amazon.com, Inc....
OPKO Health’s Acquisition of ModeX Therapeutics
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
Tessera Therapeutics’ $300 Million Series C Financing
Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a...